Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy
نویسندگان
چکیده
منابع مشابه
Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion.
Sanna Kotisaari,* Jarkko Romppanen,* Ulla Ågren,° Sakari Eskelinen,* Kari Punnonen* *Department of Clinical Chemistry, Kuopio University Hospital, PL 1777, Kuopio; °Students’ Health Service, Kuopio University, PL 1777, 70211 Kuopio, Finland
متن کاملComplications of Combined Treatment with Deferiprone and Desferrioxamine in Thalassemic Patients
Although successful iron chelation with deferiprone is associated with significant complications, patient’s compliance with medication regimens is of a high priority. The present study did evaluate the complications and compliance of domestically-manufactured deferiprone combined with desferrioxamine for iron chelation therapy. A total of 32 major beta thalassemic patients with cardiomyopathy w...
متن کاملEvaluation of Hearing Threshold in Patients with Beta Thalasemia Major Receiving Regular ChelationTherapy with Desferrioxamine (DFO)
The aim of this study was the evaluation of hearing threshold in patients with beta thalasemia major. For this purpose, 178 patients who were under regular chelation therapy with desferrioxamine (DFO) were selected and underwent ear, nose, throat examinations and audiological evaluations. Patients were between 4 to 25 years old and 54.9% were male and 45.1% were female. Three patients were excl...
متن کاملPrevalence of HIV Infection in Thalassemic Patients Receiving Blood Transfusion in Chaharmahal-bakhtiari Province in 2006
Background and Objective: Patients with thalassemia major have an abnormality in hemoglobin synthesis and ineffective hematopoiesis and for this reason with respect to disease severity should receive one or more fresh blood unit every 15-30 days. Since transfusion of blood products has been known as one ...
متن کاملcomplications of combined treatment with deferiprone and desferrioxamine in thalassemic patients
although successful iron chelation with deferiprone is associated with significant complications, patient’s compliance with medication regimens is of a high priority. the present study did evaluate the complications and compliance of domestically-manufactured deferiprone combined with desferrioxamine for iron chelation therapy. a total of 32 major beta thalassemic patients with cardiomyopathy w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 1994
ISSN: 0085-2538
DOI: 10.1038/ki.1994.295